Remove Branding Remove Doctors Remove Reagent
article thumbnail

Are microtaggants the key to making medicines smarter?

pharmaphorum

This increases the risk of counterfeiting and diversion, which can result in health risks and loss of trust for the consumer, and loss of revenue and reputational damage to the brand owner. Promote patient trust and brand loyalty. This could also be helpful in the case of people living with early-stage dementia.

article thumbnail

New Sandoz Board of Directors appointed

The Pharma Data

She is also a board member at BBI Solutions, a UK based diagnostic reagents and a Novo Holdings company. Shamiram holds an AB from Smith College and Doctor of Medicine as well as a Master of Public Health, both from Emory University, U.S.A. Maria holds a Juris Doctor degree from the University of Palermo, Italy.

Sales 40
article thumbnail

Transitioning Between Academia and Industry: Advice from Leading Scientists That Made the Switch

XTalks

In the beginning, I always thought I wanted to be a doctor, but then I felt it was very depressing, particularly at that time and in that particular field. So, I [decided] to go into research rather than be a doctor and see patients [such as that] young, beautiful life that you could do nothing about it.”.